Open access · OA via OpenAlex

Inflammatory biomarkers, disease activity and spinal disease measures in patients with ankylosing spondylitis after treatment with infliximab

Sudha Visvanathan, Carrie Wagner, Joseph C. Marini, Daniel Baker, Timothy Gathany, John Han, Désirée van der Heijde, Jürgen Braun

Annals of the Rheumatic Diseases · 2007 · ▲ 151 citations

Chronic inflammation Human

＋ Sign in to save

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: OpenAlex
DOI: 10.1136/ard.2007.071605
Canonical: link ↗
Fetched: 2026-07-28 MST

Cite this

APA

Visvanathan, S., Wagner, C., Marini, J.C., Baker, D., Gathany, T., Han, J., Heijde, D.V.D., & Braun, J. (2007). Inflammatory biomarkers, disease activity and spinal disease measures in patients with ankylosing spondylitis after treatment with infliximab. <em>Annals of the Rheumatic Diseases</em>. https://doi.org/10.1136/ard.2007.071605

Vancouver

Visvanathan S, Wagner C, Marini JC, Baker D, Gathany T, Han J, et al. Inflammatory biomarkers, disease activity and spinal disease measures in patients with ankylosing spondylitis after treatment with infliximab. Annals of the Rheumatic Diseases. 2007. doi:10.1136/ard.2007.071605.

BibTeX

@article{sudha2007Inflam, title = {Inflammatory biomarkers, disease activity and spinal disease measures in patients with ankylosing spondylitis after treatment with infliximab}, author = {Sudha Visvanathan and Carrie Wagner and Joseph C. Marini and Daniel Baker and Timothy Gathany and John Han and Désirée van der Heijde and Jürgen Braun}, journal = {Annals of the Rheumatic Diseases}, year = {2007}, doi = {10.1136/ard.2007.071605}, }